An antigen-binding molecule that specifically binds BCMA and CD3 and the pharmaceutical use thereof

The present disclosure relates to an antigen-binding molecule that specifically binds BCMA and CD3 and the pharmaceutical use thereof.

Saved in:
Bibliographic Details
Main Authors YING, HUA, TAO, WEI-KANG, SHI, JIN-PING, LI, TING-TING
Format Patent
LanguageChinese
English
Published 01.12.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure relates to an antigen-binding molecule that specifically binds BCMA and CD3 and the pharmaceutical use thereof.
Bibliography:Application Number: TW202211102409